奔月生物 (873255.OC)

+ 收藏

利润表(奔月生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 49,745,224.4655,526,412.5721,261,159.4181,032,801.1034,223,787.07
 营业收入(元) 49,745,224.4655,526,412.5721,261,159.4181,032,801.1034,223,787.07
二、营业总成本(元) 46,453,498.6756,662,009.3622,401,619.2377,828,030.6032,045,886.84
 营业成本(元) 38,408,051.8245,623,416.1317,869,394.1465,194,721.3025,434,525.12
 研发费用(元) 3,858,214.444,278,551.851,507,120.456,418,085.863,889,001.18
 营业税金及附加(元) 236,677.29538,704.58213,235.39579,810.00220,475.51
 销售费用(元) 1,153,522.641,210,676.50547,125.48805,165.40328,050.09
 管理费用(元) 2,136,453.803,904,491.351,845,700.723,746,734.951,627,018.61
 财务费用(元) 660,578.681,106,168.95419,043.051,083,513.09546,816.33
  其中:利息费用(元) 691,658.481,273,667.36548,905.031,142,475.89564,393.39
  其中:利息收入(元) 27,021.78141,274.21122,281.1226,371.888,699.22
三、其他经营收益
 资产处置收益(元) 1,004.15--22,386.89-
 信用减值损失(元) -497,280.77534,771.3061,528.38175,199.30
 其他收益(元) -353,389.48198,756.88522,876.57329,276.57
四、营业利润(元) 3,292,729.94-284,926.54-406,931.643,811,562.342,682,376.10
 加:营业外收入(元) 650,303.741.360.3514.7314.28
 减:营业外支出(元) 68,493.7319,354.30300.005,028.76111.74
五、利润总额(元) 3,874,539.95-304,279.48-407,231.293,806,548.312,682,278.64
 减:所得税费用(元) -9,343.84-428,817.96-148,199.51-202,918.53-77,609.68
六、净利润(元) 3,883,883.79124,538.48-259,031.784,009,466.842,759,888.32
(一)按经营持续性分类
  持续经营净利润(元) -124,538.48-259,031.784,009,466.842,759,888.32
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 3,883,883.79235,524.29-259,031.784,009,466.842,759,888.32
  少数股东损益(元) --110,985.81---
 扣除非经常性损益后的净利润(元) 3,775,883.47-46,539.27-427,675.433,551,009.142,480,086.08
七、每股收益
 一、基本每股收益(元) 0.120.01-0.010.180.08
 二、稀释每股收益(元) 0.120.01-0.010.180.08
九、综合收益总额(元) 3,883,883.79124,538.48-259,031.784,009,466.842,759,888.32
 归属于母公司所有者的综合收益总额(元) 3,883,883.79235,524.29-259,031.784,009,466.842,759,888.32
 归属于少数股东的综合收益总额(元) --110,985.81---
公告日期 2024-08-052024-04-162023-08-292023-04-182022-08-16
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院